Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302210 · ClinicalTrials.gov registry record
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 22,302
- Enrollment target
NCT01302210 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 22,302 participants.
The verdict
NCT01302210 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 22,302 participants
- Enrollment target
Study Summary
Our hypothesis for the DERAIL MRSA program is that one can safely remove the colonization risk from nearly all residents (patients) in a way that does not interfere with the desired life-style for persons in these facilities and thereby reduce the risk of infection and lower the cost of care by avoiding preventable disease.
Interventions
- DRUG Decolonization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,302 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302210
The ClinicalTrials.gov registry entry for NCT01302210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22,302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decolonization is the first listed.
NCT01302210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302210 about?
NCT01302210 is a clinical study titled "Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities". Our hypothesis for the DERAIL MRSA program is that one can safely remove the colonization risk from nearly all residents (patients) in a way that does not interfere with the desired life-style for persons in these facilities and thereby reduce the risk of infection and lower the cost of care by avoi...
What is the current status of trial NCT01302210?
This trial is currently completed. The enrollment target is 22,302 participants. The study started on 2010-10. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01302210?
The interventions under investigation include: Decolonization (DRUG).
Who is sponsoring clinical trial NCT01302210?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.